Essink BJ, Vermeulen W, Andrade C, de Rooij R, et al. Corrigendum to 'A randomised phase 2 immunogenicity and safety study of a MF59-adjuvanted quadrivalent subunit inactivated cell-derived influenza vaccine (aQIVc) in adults aged 50 years and older' Vaccine 51 (2025) 126791. Vaccine 2025;56:127127.
PMID: 40286564